Evidence map›Paper›PMID 27357630›Full record

ArticleMolecular medicine reports2016

Contribution of human osteoblasts and macrophages to bone matrix degradation and proinflammatory cytokine release after exposure to abrasive endoprosthetic wear particles.

Anika Jonitz-Heincke, Katrin Lochner, Christoph Schulze, Diana Pohle, Wera Pustlauk, Doris Hansmann, Rainer Bader

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. The Effects of Biomaterial Implant Wear Debris on Osteoblasts.Frontiers in cell and developmental biology · 2020
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Anika Jonitz-HeinckeDepartment of Orthopedics, Biomechanics and Implant Technology Research Laboratory, University Medical Center Rostock, Rostock 18057, Germany.
Katrin LochnerDepartment of Orthopedics, Biomechanics and Implant Technology Research Laboratory, University Medical Center Rostock, Rostock 18057, Germany.
Christoph SchulzeDepartment of Orthopedics, Biomechanics and Implant Technology Research Laboratory, University Medical Center Rostock, Rostock 18057, Germany.
Diana PohleDepartment of Immunology, University Medical Center Rostock, Rostock 18057, Germany.
Wera PustlaukDepartment of Orthopedics, Biomechanics and Implant Technology Research Laboratory, University Medical Center Rostock, Rostock 18057, Germany.
Doris HansmannDepartment of Orthopedics, Biomechanics and Implant Technology Research Laboratory, University Medical Center Rostock, Rostock 18057, Germany.
Rainer BaderDepartment of Orthopedics, Biomechanics and Implant Technology Research Laboratory, University Medical Center Rostock, Rostock 18057, Germany.
University of Rostock · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the major reasons for failure after total joint arthroplasty is aseptic loosening of the implant. At articulating surfaces, defined as the interface between implant and surrounding bone cement, wear particles can be generated and released into the periprosthetic tissue, resulting in inflammation and osteolysis. The aim of the present study was to evaluate the extent to which osteoblasts and macrophages are responsible for the osteolytic and inflammatory reactions following contact with generated wear particles from Ti‑6Al‑7Nb and Co‑28Cr‑6Mo hip stems. To this end, human osteoblasts and THP‑1 monocytic cells were incubated with the experimentally generated wear particles as well as reference particles (0.01 and 0.1 mg/ml) for 48 h under standard culture conditions. To evaluate the impact of these particles on the two cell types, the release of different bone matrix degrading matrix metalloproteinases (MMPs), tissue inhibitors of MMPs (TIMPs), and relevant cytokines were determined by multiplex enzyme‑linked immunosorbent assays. Following incubation with wear particles, human osteoblasts showed a significant upregulation of MMP1 and MMP8, whereas macrophages reacted with enhanced MMP3, MMP8 and MMP10 production. Moreover, the synthesis of TIMPs 1 and 2 was inhibited. The osteoblasts and macrophages also responded with modified expression of the inflammatory mediators interleukin (IL)‑6, IL‑8, monocyte chemoattractant protein‑1 and vascular endothelial growth factor. These results demonstrate that the release of wear particles affects the release of proinflammatory cytokines and has a negative impact on bone matrix formation during the first 48 h of particle exposure. Human osteoblasts are directly involved in the proinflammatory cascade of bone matrix degradation. The simultaneous activation and recruitment of monocytes/macrophages boosted osteolytic processes in the periprosthetic tissue. By the downregulation of TIMP production and the concomitant upregulation of MMPs as a response to particle exposure, bone formation around implants may be suppressed, resulting in implant failure.

Indexed as

Arthroplasty, ReplacementBone MatrixCell LineCells, CulturedCytokinesGene ExpressionHumansInflammation MediatorsMacrophagesMatrix MetalloproteinasesOsteoblastsOsteolysisProstheses and ImplantsTissue Inhibitor of MetalloproteinasesCytokinesInflammation MediatorsMatrix MetalloproteinasesTissue Inhibitor of Metalloproteinases

Identifiers

PMID27357630
PMCPMC4940096
OpenAlexW2472990867

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.